Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Preferences for health economics presentations among vaccine policymakers and researchers.

Richardson JS, Messonnier ML, Prosser LA.

Vaccine. 2018 Oct 15;36(43):6416-6423. doi: 10.1016/j.vaccine.2018.08.049. Epub 2018 Sep 17.

2.

School-Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program.

Basurto-Dávila R, Meltzer MI, Mills DA, Beeler Asay GR, Cho BH, Graitcer SB, Dube NL, Thompson MG, Patel SA, Peasah SK, Ferdinands JM, Gargiullo P, Messonnier M, Shay DK.

Health Serv Res. 2017 Dec;52 Suppl 2:2307-2330. doi: 10.1111/1475-6773.12786.

3.

Factors associated with the pricing of childhood vaccines in the U.S. public sector.

Chen W, Messonnier M, Zhou F.

Health Econ. 2018 Feb;27(2):252-265. doi: 10.1002/hec.3539. Epub 2017 Jun 29.

PMID:
28660666
4.

Corrigendum to "Trends in childhood vaccine purchase costs in the US public sector: 1996-2014" [Vaccine 34 (2016) 4706-4711].

Chen W, Messonnier M, Zhou F.

Vaccine. 2017 Jan 23;35(4):711. doi: 10.1016/j.vaccine.2016.12.010. Epub 2016 Dec 26. No abstract available.

PMID:
28034475
5.

Trends in childhood vaccine purchase costs in the US public sector: 1996-2014.

Chen W, Messonnier M, Zhou F.

Vaccine. 2016 Sep 7;34(39):4706-4711. doi: 10.1016/j.vaccine.2016.08.012. Epub 2016 Aug 10. Erratum in: Vaccine. 2017 Jan 23;35(4):711.

PMID:
27522176
6.

Hitting the Optimal Vaccination Percentage and the Risks of Error: Why to Miss Right.

Harvey MJ, Prosser LA, Messonnier ML, Hutton DW.

PLoS One. 2016 Jun 22;11(6):e0156737. doi: 10.1371/journal.pone.0156737. eCollection 2016.

7.

Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women.

Xu J, Zhou F, Reed C, Chaves SS, Messonnier M, Kim IK.

Vaccine. 2016 Jun 8;34(27):3149-3155. doi: 10.1016/j.vaccine.2016.04.057. Epub 2016 May 6.

PMID:
27161997
8.

Impact and cost-effectiveness of a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine dose to prevent pertussis in the United States.

Kamiya H, Cho BH, Messonnier ML, Clark TA, Liang JL.

Vaccine. 2016 Apr 4;34(15):1832-8. doi: 10.1016/j.vaccine.2016.02.027. Epub 2016 Feb 17.

PMID:
26899377
9.

Adolescent girls' preferences for HPV vaccines: a discrete choice experiment.

Brown DS, Poulos C, Johnson FR, Chamiec-Case L, Messonnier ML.

Adv Health Econ Health Serv Res. 2014;24:93-121.

PMID:
25244906
10.

Economic evaluation of the routine childhood immunization program in the United States, 2009.

Zhou F, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A, Moore M, Murphy TV, Cortese M, Rodewald L.

Pediatrics. 2014 Apr;133(4):577-85. doi: 10.1542/peds.2013-0698. Epub 2014 Mar 3.

PMID:
24590750
11.

Parent attitudes about school-located influenza vaccination clinics.

Brown DS, Arnold SE, Asay G, Lorick SA, Cho BH, Basurto-Davila R, Messonnier ML.

Vaccine. 2014 Feb 19;32(9):1043-8. doi: 10.1016/j.vaccine.2014.01.003. Epub 2014 Jan 15.

PMID:
24440111
12.

Bridging the gap: a collaborative to reduce peripherally inserted central catheter infections in the home care environment.

Baumgarten K, Hale Y, Messonnier M, McCabe M, Albright M, Bergeron E.

Ochsner J. 2013 Fall;13(3):352-8.

13.

Cost-effectiveness of using 2 vs 3 primary doses of 13-valent pneumococcal conjugate vaccine.

Stoecker C, Hampton LM, Link-Gelles R, Messonnier ML, Zhou F, Moore MR.

Pediatrics. 2013 Aug;132(2):e324-32. doi: 10.1542/peds.2012-3350. Epub 2013 Jul 1.

PMID:
23821695
14.

Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.

Terranella A, Asay GR, Messonnier ML, Clark TA, Liang JL.

Pediatrics. 2013 Jun;131(6):e1748-56. doi: 10.1542/peds.2012-3144. Epub 2013 May 27.

PMID:
23713104
15.

Using a discrete choice experiment to elicit time trade-off and willingness-to-pay amounts for influenza health-related quality of life at different ages.

Prosser LA, Payne K, Rusinak D, Shi P, Messonnier M.

Pharmacoeconomics. 2013 Apr;31(4):305-15. doi: 10.1007/s40273-013-0029-6.

PMID:
23512145
16.

Costs of school-located influenza vaccination clinics in Maine during the 2009-2010 H1N1 pandemic.

Cho BH, Asay GR, Lorick SA, Tipton ML, Dube NL, Messonnier ML.

J Sch Nurs. 2012 Oct;28(5):336-43. Epub 2012 Aug 22.

PMID:
22914801
17.

Coordination costs for school-located influenza vaccination clinics, Maine, 2009 H1N1 pandemic.

Asay GR, Cho BH, Lorick SA, Tipton ML, Dube NL, Messonnier ML.

J Sch Nurs. 2012 Oct;28(5):328-35. Epub 2012 Jun 11.

PMID:
22691394
18.

Parental and societal values for the risks and benefits of childhood combination vaccines.

Gidengil C, Lieu TA, Payne K, Rusinak D, Messonnier M, Prosser LA.

Vaccine. 2012 May 14;30(23):3445-52. doi: 10.1016/j.vaccine.2012.03.022. Epub 2012 Mar 23.

PMID:
22449423
19.

Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.

Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA.

Drugs. 2012 Jan 1;72(1):35-48. doi: 10.2165/11597310-000000000-00000. Review.

PMID:
22191794
20.

Financing and systems barriers to seasonal influenza vaccine delivery in community settings.

Penfold RB, Rusinak D, Lieu TA, Shefer A, Messonnier M, Lee GM.

Vaccine. 2011 Dec 6;29(52):9632-9. doi: 10.1016/j.vaccine.2011.10.041. Epub 2011 Oct 25.

PMID:
22036886
21.

Valuing health across the lifespan: health state preferences for seasonal influenza illnesses in patients of different ages.

Prosser LA, Payne K, Rusinak D, Shi P, Uyeki T, Messonnier M.

Value Health. 2011 Jan;14(1):135-43. doi: 10.1016/j.jval.2010.10.026.

22.

A tool for the economic analysis of mass prophylaxis operations with an application to H1N1 influenza vaccination clinics.

Cho BH, Hicks KA, Honeycutt AA, Hupert N, Khavjou O, Messonnier M, Washington ML.

J Public Health Manag Pract. 2011 Jan-Feb;17(1):E22-8. doi: 10.1097/PHH.0b013e3181f87952.

PMID:
21135651
23.

Financial barriers to the adoption of combination vaccines by pediatricians.

Gidengil CA, Dutta-Linn MM, Messonnier ML, Rusinak D, Lieu TA.

Arch Pediatr Adolesc Med. 2010 Dec;164(12):1138-44. doi: 10.1001/archpediatrics.2010.222.

PMID:
21135343
24.

Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus.

Brown DS, Johnson FR, Poulos C, Messonnier ML.

Vaccine. 2010 Feb 17;28(7):1702-8. doi: 10.1016/j.vaccine.2009.12.024. Epub 2009 Dec 29.

PMID:
20044060
25.

MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approach.

Cho BH, Clark TA, Messonnier NE, Ortega-Sanchez IR, Weintraub E, Messonnier ML.

Vaccine. 2010 Jan 8;28(3):817-22. doi: 10.1016/j.vaccine.2009.10.050. Epub 2009 Oct 30.

PMID:
19879992
26.

Influenza vaccination coverage rate among high-risk children during the 2002-2003 influenza season.

Cho BH, Kolasa MS, Messonnier ML.

Am J Infect Control. 2008 Oct;36(8):582-7. doi: 10.1016/j.ajic.2007.09.013.

PMID:
18926312
27.

The role of economic information in decision-making by the Advisory Committee on Immunization Practices.

Dempsey AF, Cowan AE, Stokley S, Messonnier M, Clark SJ, Davis MM.

Vaccine. 2008 Oct 3;26(42):5389-92. doi: 10.1016/j.vaccine.2008.07.085. Epub 2008 Aug 15.

PMID:
18708111
28.

The impact of gaps in health insurance coverage on immunization status for young children.

Blewett LA, Davidson G, Bramlett MD, Rodin H, Messonnier ML.

Health Serv Res. 2008 Oct;43(5 Pt 1):1619-36. doi: 10.1111/j.1475-6773.2008.00864.x. Epub 2008 Jun 3.

29.

Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.

Prosser LA, O'Brien MA, Molinari NA, Hohman KH, Nichol KL, Messonnier ML, Lieu TA.

Pharmacoeconomics. 2008;26(2):163-78.

PMID:
18198935
30.

Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.

Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, Zhang X, Stephens DS, Messonnier NE; Active Bacterial Core Surveillance Team.

Clin Infect Dis. 2008 Jan 1;46(1):1-13. doi: 10.1086/524041.

PMID:
18171206
31.

A new model of adoption of clinical practice guidelines.

Fontanesi J, Messonnier M, Hill L, Shefer A.

J Public Health Manag Pract. 2007 Nov-Dec;13(6):605-11.

PMID:
17984715
32.

Out-of-pocket costs of childhood immunizations: a comparison by type of insurance plan.

Molinari NA, Kolasa M, Messonnier ML, Schieber RA.

Pediatrics. 2007 Nov;120(5):e1148-56.

PMID:
17974710
33.

Gaps in vaccine financing for underinsured children in the United States.

Lee GM, Santoli JM, Hannan C, Messonnier ML, Sabin JE, Rusinak D, Gay C, Lett SM, Lieu TA.

JAMA. 2007 Aug 8;298(6):638-43.

PMID:
17684186
34.

The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB.

Vaccine. 2007 Jun 28;25(27):5086-96. Epub 2007 Apr 20.

PMID:
17544181
35.

Economics and public health at CDC.

Messonnier ML; Centers for Disease Control and Prevention.

MMWR Suppl. 2006 Dec 22;55(2):17-9.

PMID:
17183241
36.

Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.

Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.

Arch Pediatr Adolesc Med. 2005 Dec;159(12):1136-44.

PMID:
16330737
37.

Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti.

Rheingans RD, Haddix AC, Messonnier ML, Meltzer M, Mayard G, Addiss DG.

Filaria J. 2004 Jan 30;3(1):2.

38.
39.

Disability and its economic impact among adults with diabetes.

Yassin AS, Beckles GL, Messonnier ML.

J Occup Environ Med. 2002 Feb;44(2):136-42.

PMID:
11851214
40.

A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma.

Bousquet J, Ben-Joseph R, Messonnier M, Alemao E, Gould AL.

Clin Ther. 2002 Jan;24(1):1-20.

PMID:
11833824
41.

Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services. Task Force on Community Preventive Services.

Carande-Kulis VG, Maciosek MV, Briss PA, Teutsch SM, Zaza S, Truman BI, Messonnier ML, Pappaioanou M, Harris JR, Fielding J.

Am J Prev Med. 2000 Jan;18(1 Suppl):75-91.

PMID:
10806980
42.

Economic models of hepatitis A virus immunization.

Meltzer M, Messonnier ML.

Hepatology. 1999 Jul;30(1):343; author reply 344-5. No abstract available.

PMID:
10428626
43.

An ounce of prevention ... what are the returns? Second edition, 1999.

Messonnier ML, Corso PS, Teutsch SM, Haddix AC, Harris JR.

Am J Prev Med. 1999 Apr;16(3):248-63. Review.

PMID:
10198666

Supplemental Content

Loading ...
Support Center